Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From Aug 01, 2023

Rossari Biotech Q1 Results Review - Weak Raw Material Prices Led To Tepid Earnings Growth: Yes Securities

Rossari Biotech reported operating profits at Rs 577 million.

Rossari Biotech Q1 Results Review - Weak Raw Material Prices Led To Tepid Earnings Growth: Yes Securities
Global chemical companies have issued warnings of a demand slowdown, which will also impact those from India. (Source: Freepik)

BQ Prime's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer BQ Prime's subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Yes Securities Report

Rossari Biotech Ltd.'s reported operating profits at Rs 577 million (flat YoY; +6% QoQ). The Ebitda margin at 14.1% (Q4: 13.4%) improved marginally due to lower employee cost.

The standalone earnings stood stronger with standalone Ebitda at Rs 351 million growing by 30% YoY and -2% QoQ, driven by a 11% YoY and -2% QoQ growth in revenue and a constant Ebitda margin of 13.6%.

Revenue was supported from new product introduction in home, personal care, and performance chemicals, while there was impact of global destocking in textile specialty chemicals and animal health and nutrition having a seasonally weak quarter.

Rossari acquired 16% of remaining stake in Tristar Intermediates for a consideration of Rs 169 million. Research and development team working towards providing sustainable aquaculture solutions for farmers.

For FY24 target revenue growth of 12- 14% and Ebitda margin of 12%. Rossari has its R&D at core and customisation through which it aims to deliver growth in volatile macro scenario.

We maintain 'Buy' rating with revised target price of Rs 1,030/share.

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search
Add NDTV Profit As Google Preferred Source